Maged Shenouda

Maged Shenouda

Director of Finance/CFO presso RELMADA THERAPEUTICS, INC.

Patrimonio netto: 162 299 $ in data 31/03/2024

59 anni
Health Technology
Finance
Commercial Services

Profilo

Maged S.
Shenouda
is currently the Chief Financial Officer at Relmada Therapeutics, Inc. He previously worked as a Director at Protea Biosciences, Inc. and Protea Biosciences Group, Inc. He also served as a Managing Director at Blueprint Life Science Group and Stifel, Nicolaus & Co., Inc. Maged has experience as an Analyst at Bear, Stearns & Co., Inc., UBS Securities LLC, and JPMorgan Securities LLC.
He has also worked as a Principal at Abbott Laboratories and as a Management Consultant at Pricewaterhouse & Co. Additionally, Maged held positions as a Senior VP, Head-Business Development & Licensing at Travere Therapeutics, Inc., Chief Financial & Accounting Officer at First Wave Biopharma, Inc., and Head-Business Development & Licensing at Retrophin, Inc. Maged completed his undergraduate studies at St. John's University and holds an MBA from Rutgers Business School.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
31/01/2024 34 903 ( 0.12% ) 162 299 $ 31/03/2024

Posizioni attive di Maged Shenouda

SocietàPosizioneInizio
RELMADA THERAPEUTICS, INC. Director of Finance/CFO 09/01/2020
Tutte le posizioni attive di Maged Shenouda

Precedenti posizioni note di Maged Shenouda

SocietàPosizioneFine
FIRST WAVE BIOPHARMA, INC. Director of Finance/CFO 01/12/2019
PROTEA BIOSCIENCES GROUP, INC Director/Board Member 09/06/2017
TRAVERE THERAPEUTICS, INC. Corporate Officer/Principal 01/11/2014
Blueprint Life Science Group Corporate Officer/Principal 01/09/2013
Vedi nel dettaglio l'esperienza di Maged Shenouda

Formazione di Maged Shenouda

St. John's University Undergraduate Degree
Rutgers Business School Masters Business Admin

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Maged Shenouda

Relazioni

100 +

Relazioni di 1° grado

15

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa4
ABBOTT LABORATORIES

Health Technology

TRAVERE THERAPEUTICS, INC.

Health Technology

FIRST WAVE BIOPHARMA, INC.

Health Technology

RELMADA THERAPEUTICS, INC.

Health Technology

Aziende private9

Finance

Finance

Finance

Health Technology

Finance

Pricewaterhouse & Co.

Commercial Services

Salomon Smith Barney

Finance

Commercial Services

Blueprint Life Science Group

Vedi le connessioni aziendali
  1. Borsa valori
  2. Insiders
  3. Maged Shenouda